156
Participants
Start Date
June 30, 2008
Primary Completion Date
November 11, 2008
Study Completion Date
November 11, 2008
Once-daily aclidinium/formoterol
Inhaled aclidinium bromide 200 µg/formoterol fumarate 12 µg fixed-dose combination once-daily in the morning
Twice-daily formoterol fumarate
Inhaled formoterol fumarate 12 µg twice-daily (BID)
Placebo to formoterol fumarate
Inhaled placebo to formoterol fumarate once-daily in the evening
Once-daily formoterol fumarate
Inhaled formoterol fumarate 12 μg once-daily in the evening
Forest Investigative Site, Albany
Forest Investigative Site, Pittsburgh
Forest Investigative Site, Richmond
Forest Investigative Site, Charlotte
Forest Investigative Site, Spartanburg
Forest Investigative Site, Austell
Forest Investigative Site, Atlanta
Forest Investigative Site, Blue Ridge
Forest Investigative Site, Panama City
Forest Investigative Site, DeLand
Forest Investigative Site, Tamarac
Forest Investigative Site, Tampa
Forest Investigative Site, Hazard
Forest Investigative Site, Bowling Green
Forest Investigative Site, Columbus
Forest Investigative Site, Cincinnati
Forest Investigative Site, Milwaukee
Forest Investigative Site, Rochester
Forest Investigative Site, Florissant
Forest Investigative Site, St Louis
Forest Investigative Site, Saint Charles
Forest Investigative Site, McKinney
Forest Investigative Site, Dallas
Forest Investigative Site, Wheat Ridge
Forest Investigative Site, Midvale
Forest Investigative Site, Tucson
Forest Investigative Site, Tucson
Forest Investigative Site, Lakewood
Forest Investigative Site, San Diego
Forest Investigative Site, Rancho Mirage
Forest Investigative Site, Redlands
Forest Investigative Site, Fullerton
Forest Investigative Site, San Jose
Forest Investigative Site, Stockton
Forest Investigative Site, Medford
Forest Investigative Site, Hartford
Forest Investigative Site, New Britain
Forest Investigative Site, Waterbury
Forest Investigative Site, North Dartmouth
Forest Investigative Site, East Providence
Lead Sponsor
AstraZeneca
INDUSTRY